We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$221M
AUM Growth
-$8.44M
Cap. Flow
-$62.1M
Cap. Flow %
-28.07%
Top 10 Hldgs %
71.31%
Holding
41
New
4
Increased
2
Reduced
9
Closed
7

Top Buys

Rank Stock Value
1
COL
Rockwell Collins
COL
+$16.7M
2
IBB icon
iShares Biotechnology ETF
IBB
+$7.13M
3
ZGNX
Zogenix, Inc.
ZGNX
+$1.76M
4
W icon
Wayfair
W
+$1.45M
5
MON
Monsanto Co
MON
+$674K

Top Sells

Rank Stock Value
1
CPN
Calpine Corporation
CPN
+$16.7M
2
AKRX
Akorn Inc
AKRX
+$9.79M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$6.02M
4
NXTM
NxStage Medical Inc.
NXTM
+$4.61M
5
PPLI
People Inc
PPLI
+$3.45M

Sector Composition

Rank Sector Weight
1 Communication Services 30.58%
2 Materials 14.32%
3 Healthcare 3.62%
4 Financials 1.17%
5 Consumer Discretionary 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MON
1
DELISTED
Monsanto Co
MON
$31.4M 14.18%
268,817
+5,600
+2% +$674K
TWX
2
DELISTED
Time Warner Inc
TWX
$23.9M 10.78%
252,013
-11,500
-4% -$1.08M
PPLI
3
People Inc
PPLI
$3.1B
$21.1M 9.56%
756,454
-130,933
-15% -$3.45M
TRCO
4
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$20.9M 9.44%
515,731
– –
COL
5
DELISTED
Rockwell Collins
COL
$16.6M 7.48%
+122,499
New +$16.7M
DISCK
6
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$16.4M 7.41%
840,337
-268,875
-24% -$6.02M
IBB icon
7
iShares Biotechnology ETF
IBB
$9.31B
$6.86M 3.1%
+64,300
New +$7.13M
RDNT icon
8
RadNet
RDNT
$4.84B
$4.98M 2.25%
346,293
-1,200
-0.3% -$13.1K
AKRX
9
DELISTED
Akorn Inc
AKRX
$3.74M 1.69%
200,000
-361,154
-64% -$9.79M
APO icon
10
Apollo Global Management
APO
$70.7B
$2.59M 1.17%
87,418
-27,382
-24% -$921K
W icon
11
Wayfair
W
$11.1B
$2.52M 1.14%
37,300
+17,250
+86% +$1.45M
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
$1.78M 0.81%
+44,500
New +$1.76M
GTT
13
DELISTED
GTT Communications, Inc.
GTT
$1.77M 0.8%
31,238
-13,500
-30% -$666K
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$312M
$692K 0.31%
41,000
-33,000
-45% -$552K
BCRX icon
15
BioCryst Pharmaceuticals
BCRX
$2.37B
$477K 0.22%
+100,000
New +$514K
B
16
Barrick Mining
B
$62.2B
$311K 0.14%
25,000
– –
SGYP
17
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$91K 0.04%
50,000
-156,500
-76% -$331K
COOP
18
DELISTED
Mr. Cooper
COOP
– –
-9,167
Closed -$94K
NDAQ icon
19
Nasdaq
NDAQ
$52.1B
– –
-12,915
Closed -$331K
SBGI icon
20
Sinclair Inc
SBGI
$974M
– –
-40,000
Closed -$1.51M
AUD
21
DELISTED
Audacy, Inc.
AUD
– –
-170,000
Closed -$1.84M
ADMS
22
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-100,000
Closed -$3.39M
NXTM
23
DELISTED
NxStage Medical Inc.
NXTM
– –
-190,000
Closed -$4.61M
CPN
24
DELISTED
Calpine Corporation
CPN
– –
-1,101,065
Closed -$16.7M

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return
TCM
TORQ Capital Management Hong Kong $38.1M AUM 2.81% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Cheyne Capital Management (UK)'s Q1 2018 Portfolio in Review

As of Q1 2018, Cheyne Capital Management (UK) held 41 positions worth $221M, down 3.7% from $230M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Cheyne Capital Management (UK) withdrew a net $62.1M in Q1 2018, closing 7 positions and reducing 9 holdings. Its most notable exit was Calpine Corporation, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 31% of assets, down from 31% a quarter earlier, followed by Materials and Healthcare.

Against the trend, Cheyne Capital Management (UK) opened a new position in Rockwell Collins worth $16.6M.

  • Cheyne Capital Management (UK)'s largest Q1 2018 buy was Rockwell Collins: 122,499 shares worth $16.6M.
  • Cheyne Capital Management (UK) added most to Wayfair in Q1 2018, an estimated $1.45M increase.
  • Cheyne Capital Management (UK)'s biggest Q1 2018 reduction was Akorn Inc, cutting an estimated $9.79M.
  • Cheyne Capital Management (UK) fully exited Calpine Corporation in Q1 2018, selling an estimated $16.7M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 71% of its $221M portfolio in Q1 2018.
  • Cheyne Capital Management (UK) opened 4 new positions and closed 7 in Q1 2018.
  • Cheyne Capital Management (UK)'s portfolio value fell 3.7% quarter-over-quarter to $221M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2018, filed 10 May 2018.